28 results
Thumbnail

D3.323 - SBK007: A Novel Oral H1 Antihistamine with Rapid Onset (30min): Preclinical Pharmacodynamics in Acute Urticaria

Thumbnail

D3.324 - Hereditary Angioedema Attack Frequency and Severity According to Individuals Taking Berotralstat for Long-Term Prophylaxis

Thumbnail

D3.325 - Immediate-type allergic reactions associated with thiuram mix sensitization in an adolescent with atopic dermatitis: a case report

Thumbnail

D3.328 - Paediatric Anaphylaxis: The Importance Of Recognition

Thumbnail

D3.329 - Real-world shelf-life of adrenaline auto-injectors (AAIs) at pharmacy dispensing: Insights from six countries

Thumbnail

D3.331 - Real-World Challenges in Pediatric Anaphylaxis: The Role of Epinephrine

Thumbnail

D3.332 - Patient Preferences for Nasal Adrenaline Spray versus Adrenaline Auto-Injectors in Anaphylaxis: A Multi-Country Discrete Choice Experiment

Thumbnail

D3.333 - Clinical Characteristics of Anaphylaxis in Infants and Toddlers

Thumbnail

D3.334 - Severe Early-Onset Atopy With Recurrent Anaphylaxis and Infections as Indicators of CADINS Disease

Thumbnail

D3.335 - Anaphylaxis After Eating Sushi - Emergent allergies with new food habits?

Thumbnail

D3.430 - The effect of biological treatment of atopic dermatitis in children

Thumbnail

D3.431 - Dupilumab therapy of patients with chronic rhinosinusitis with nasal polyps: long-term observational study

Thumbnail

D3.432 - Severe chronic rhinosinusitis - diagnostic and therapeutic challenges, personalized approach and place of biological treatment: a clinical case

Thumbnail

D3.433 - An effect on lipid profile of biologic therapy independent from weight variation

Thumbnail

D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data

Thumbnail

D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial